Experts call for a shift from reactive to proactive clinical trial supply frameworks
With supply chain disruptions becoming worse and more frequent over the past decade, moving from a paradigm of reactiveness to…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.
-
-
Supply chains too often “last cog” implemented in clinical trials
Placing emphasis on supply chains before initiating a clinical trial can help create protocols that are robust against delays, unlike…
-
“Systematic reviews” for underrepresented groups in trials needed, says WHO senior adviser
Systematic reviews are needed to address gaps in population representation in clinical trials to ensure the quality level of evidence…
-
“Preparation key” to prevent airfreight transit delay of medicines to clinical trials
Airline passenger numbers may have been slow to rise after the Covid-19 pandemic, but air cargo’s rebound was much quicker.…
-
Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons
Southeast Asia offers a unique opportunity for sponsors conducting clinical trials with vaccine candidates including faster recruitment, lower costs, and…
-
Sequana Medical’s DSR 2.0 outperforms traditional peritoneal dialysis solutions in study
Following positive data reported earlier this year from a Phase I/II trial, Sequana Medical has touted results from a study…
-
Neuralink to launch feasibility trial with implant coupled to robotic arm
US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic…
-
Roche’s tiragolumab flops in another Phase III lung cancer trial
Roche's struggles with finding a foothold for its immune checkpoint inhibitor tiragolumab the cancer treatment space have been reinforced with…
-
Does Southeast Asia have a growing role in vaccine development?
Seoul will trade gatherings at its famous royal palaces for meetings at two key clinical trial events to be hosted…
-
AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership
AstraZeneca has exercised an option to license a cell therapy from Quell Therapeutics, resulting in a $10m milestone payment heading…